Cargando…

C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype

We previously investigated MET and its oncogenic mutants relevant to lung cancer in C. elegans. The inactive orthlogues of the receptor tyrosine kinase Eph and MET, namely vab-1 and RB2088 respectively, the temperature sensitive constitutively active form of KRAS, SD551 (let-60; GA89) and the inacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanteti, Rajani, Dhanasingh, Immanuel, El-Hashani, Essam, Riehm, Jacob J., Stricker, Thomas, Nagy, Stanislav, Zaborin, Alexander, Zaborina, Olga, Biron, David, Alverdy, John C., Im, Hae Kyung, Siddiqui, Shahid, Padilla, Pamela A., Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093410/
https://www.ncbi.nlm.nih.gov/pubmed/26574927
http://dx.doi.org/10.1080/15384047.2015.1108495
_version_ 1783347684857348096
author Kanteti, Rajani
Dhanasingh, Immanuel
El-Hashani, Essam
Riehm, Jacob J.
Stricker, Thomas
Nagy, Stanislav
Zaborin, Alexander
Zaborina, Olga
Biron, David
Alverdy, John C.
Im, Hae Kyung
Siddiqui, Shahid
Padilla, Pamela A.
Salgia, Ravi
author_facet Kanteti, Rajani
Dhanasingh, Immanuel
El-Hashani, Essam
Riehm, Jacob J.
Stricker, Thomas
Nagy, Stanislav
Zaborin, Alexander
Zaborina, Olga
Biron, David
Alverdy, John C.
Im, Hae Kyung
Siddiqui, Shahid
Padilla, Pamela A.
Salgia, Ravi
author_sort Kanteti, Rajani
collection PubMed
description We previously investigated MET and its oncogenic mutants relevant to lung cancer in C. elegans. The inactive orthlogues of the receptor tyrosine kinase Eph and MET, namely vab-1 and RB2088 respectively, the temperature sensitive constitutively active form of KRAS, SD551 (let-60; GA89) and the inactive c-CBL equivalent mutants in sli-1 (PS2728, PS1258, and MT13032) when subjected to chronic exposure of nicotine resulted in a significant loss in egg-laying capacity and fertility. While the vab-1 mutant revealed increased circular motion in response to nicotine, the other mutant strains failed to show any effect. Overall locomotion speed increased with increasing nicotine concentration in all tested mutant strains except in the vab-1 mutants. Moreover, chronic nicotine exposure, in general, upregulated kinases and phosphatases. Taken together, these studies provide evidence in support of C. elegans as initial in vivo model to study nicotine and its effects on oncogenic mutations identified in humans.
format Online
Article
Text
id pubmed-6093410
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-60934102018-08-17 C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype Kanteti, Rajani Dhanasingh, Immanuel El-Hashani, Essam Riehm, Jacob J. Stricker, Thomas Nagy, Stanislav Zaborin, Alexander Zaborina, Olga Biron, David Alverdy, John C. Im, Hae Kyung Siddiqui, Shahid Padilla, Pamela A. Salgia, Ravi Cancer Biol Ther Research Paper We previously investigated MET and its oncogenic mutants relevant to lung cancer in C. elegans. The inactive orthlogues of the receptor tyrosine kinase Eph and MET, namely vab-1 and RB2088 respectively, the temperature sensitive constitutively active form of KRAS, SD551 (let-60; GA89) and the inactive c-CBL equivalent mutants in sli-1 (PS2728, PS1258, and MT13032) when subjected to chronic exposure of nicotine resulted in a significant loss in egg-laying capacity and fertility. While the vab-1 mutant revealed increased circular motion in response to nicotine, the other mutant strains failed to show any effect. Overall locomotion speed increased with increasing nicotine concentration in all tested mutant strains except in the vab-1 mutants. Moreover, chronic nicotine exposure, in general, upregulated kinases and phosphatases. Taken together, these studies provide evidence in support of C. elegans as initial in vivo model to study nicotine and its effects on oncogenic mutations identified in humans. Taylor & Francis 2015-11-17 /pmc/articles/PMC6093410/ /pubmed/26574927 http://dx.doi.org/10.1080/15384047.2015.1108495 Text en © 2016 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Research Paper
Kanteti, Rajani
Dhanasingh, Immanuel
El-Hashani, Essam
Riehm, Jacob J.
Stricker, Thomas
Nagy, Stanislav
Zaborin, Alexander
Zaborina, Olga
Biron, David
Alverdy, John C.
Im, Hae Kyung
Siddiqui, Shahid
Padilla, Pamela A.
Salgia, Ravi
C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
title C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
title_full C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
title_fullStr C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
title_full_unstemmed C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
title_short C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
title_sort c. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093410/
https://www.ncbi.nlm.nih.gov/pubmed/26574927
http://dx.doi.org/10.1080/15384047.2015.1108495
work_keys_str_mv AT kantetirajani celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT dhanasinghimmanuel celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT elhashaniessam celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT riehmjacobj celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT strickerthomas celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT nagystanislav celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT zaborinalexander celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT zaborinaolga celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT birondavid celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT alverdyjohnc celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT imhaekyung celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT siddiquishahid celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT padillapamelaa celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype
AT salgiaravi celegansandmutantswithchronicnicotineexposureasanovelmodelofcancerphenotype